Inventor · disambiguated record
Markus Thomas
Also filed as: THOMAS MARKUS
5 granted patents·8 pending applications·145 citations·filing 2009–2023
83Inventor score
Top patents by PatentIndex Score
13 records- 0197US8268314B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2009·Granted Sep 18, 2012·70 cites·18 claims
- 0294US8945552B2Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2011·Granted Feb 3, 2015·36 cites·12 claims
- 0394US8703130B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2012·Granted Apr 22, 2014·23 cites·12 claims
- 0492US9708396B2Bispecific anti-VEGF/anti-ANG-2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Jul 18, 2017·16 cites·17 claims
- 0584US2023399391A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0672US2021047394A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0761US2017369566A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0861US2020199215A1Combination therapy with an anti-ang2 antibody and a cd40 agonistHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0961US2015232548A1Combination therapy with an anti-ANG2 antibody and a CD40 agonistHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1059US2015191535A1Bispecific, bivalent anti-vegf/anti-ang2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1156US2018134780A1Combination therapy with an anti-ang2 antibody and a cd40 agonistHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 1251US2017240626A1Bispecific, bivalent anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1349US11644472B2Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted May 9, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Markus Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →